Save time and get answers to complex questions with AI chat
When will a generic version of xiaflex be available?Campath litigation germany?Defense strategy against generic in niche market?Is guselkumab off patent in u s?Dabrafenib patent expiration date novartis gsk composition matter?
See the DrugPatentWatch profile for belsomra
What company developed and markets belsomra? Belsomra, also known as suvorexant, was developed by Merck & Co., a US-based multinational pharmaceutical company. Merck acquired the rights to the medication through their purchase of Inspire Pharmaceuticals, the original developer, in 2010. In 2014, the FDA approved belsomra for the treatment of insomnia characterized by difficulties with sleep initiation. However, due to disappointing sales, Merck discontinued belsomra in the US market in 2019.
Other Questions About Belsomra :
“was developed by Merck & Co.”